QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS FOR DETERMINGING THE PRESENCE, IDENTITY, OR SEVERITY OF A DISEASE OR CONDITION

摘要

Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.